A rapid increase in lysophospholipids after geranylgeranoic acid treatment in human hepatoma-derived HuH-7 cells revealed by metabolomics analysis

Geranylgeranoic acid (GGA) was developed as a preventative agent against second primary hepatoma, and was reported to induce cell death in human hepatoma cells via Toll-like receptor 4 (TLR4)-mediated pyroptosis. We recently reported that GGA is enzymatically biosynthesized from mevalonic acid in hu...

Descripción completa

Detalles Bibliográficos
Autores principales: Shidoji, Yoshihiro, Iwao, Chieko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8626837/
https://www.ncbi.nlm.nih.gov/pubmed/34869922
http://dx.doi.org/10.1016/j.bbrep.2021.101176

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8626837/
https://www.ncbi.nlm.nih.gov/pubmed/34869922
http://dx.doi.org/10.1016/j.bbrep.2021.101176

Ejemplares similares